• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过操控肿瘤抑制因子p53来增强癌症治疗效果。

Manipulation of the tumor suppressor p53 for potentiating cancer therapy.

作者信息

Haupt Susan, Haupt Ygal

机构信息

Department of Pharmaceutics, School of Pharmacy, The Hebrew University, Jerusalem 91120, Israel.

出版信息

Semin Cancer Biol. 2004 Aug;14(4):244-52. doi: 10.1016/j.semcancer.2004.04.003.

DOI:10.1016/j.semcancer.2004.04.003
PMID:15219617
Abstract

The tumor suppressor p53 is a linchpin in the regulation of appropriate cellular responses to various stress conditions. Inactivation of the functions of this critical participant can have diabolical consequences, in particular the development of malignant diseases. Elicitation of appropriate p53 functions is an attractive strategy for combating cancer. Triggering p53 responses, reconstituting p53 activities through gene therapy, coercing mutant p53 to perform normal functions, manipulating p53 regulators, and activating p53 effectors are all approaches that are currently being developed. Here, we will overview 'p53-based' strategies for fighting cancer, both those under clinical trial and recent innovative concepts.

摘要

肿瘤抑制因子p53是调控细胞对各种应激条件做出适当反应的关键因素。这个关键参与者功能的失活可能会产生极其严重的后果,尤其是引发恶性疾病。激发p53的适当功能是对抗癌症的一个有吸引力的策略。触发p53反应、通过基因疗法重建p53活性、迫使突变型p53发挥正常功能、操纵p53调节因子以及激活p53效应器都是目前正在研发的方法。在此,我们将概述用于对抗癌症的“基于p53”的策略,包括那些正在进行临床试验的策略以及近期的创新理念。

相似文献

1
Manipulation of the tumor suppressor p53 for potentiating cancer therapy.通过操控肿瘤抑制因子p53来增强癌症治疗效果。
Semin Cancer Biol. 2004 Aug;14(4):244-52. doi: 10.1016/j.semcancer.2004.04.003.
2
P53 tumor suppressor gene therapy for cancer.用于癌症治疗的P53肿瘤抑制基因疗法。
Cancer Gene Ther. 1998 Jan-Feb;5(1):52-63.
3
In search of p53 target genes for the therapeutic manipulation of cancer.寻找用于癌症治疗性调控的p53靶基因。
Curr Opin Drug Discov Devel. 2006 Mar;9(2):176-83.
4
Improving cancer therapy through p53 management.通过p53调控改善癌症治疗
Cell Cycle. 2004 Jul;3(7):912-6. Epub 2004 Jul 2.
5
p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.p51/p63,一种新型p53同源物,增强p53活性,是人类癌症基因治疗的候选对象。
J Gene Med. 2006 Sep;8(9):1121-30. doi: 10.1002/jgm.945.
6
Structural and functional basis for therapeutic modulation of p53 signaling.p53信号通路治疗性调控的结构与功能基础
Clin Cancer Res. 2008 Oct 15;14(20):6376-86. doi: 10.1158/1078-0432.CCR-08-1526.
7
Exploiting the p53 pathway for the diagnosis and therapy of human cancer.利用p53信号通路进行人类癌症的诊断与治疗。
Cold Spring Harb Symp Quant Biol. 2005;70:489-97. doi: 10.1101/sqb.2005.70.049.
8
Wild-type p53 in cancer cells: when a guardian turns into a blackguard.癌细胞中的野生型p53:当守护者变成无赖时。
Biochem Pharmacol. 2009 Jan 1;77(1):11-20. doi: 10.1016/j.bcp.2008.08.030. Epub 2008 Sep 3.
9
Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.恢复人类肿瘤中野生型p53的功能:高效癌症治疗策略
Adv Cancer Res. 2007;97:321-38. doi: 10.1016/S0065-230X(06)97014-6.
10
Current strategies in cancer gene therapy.癌症基因治疗的当前策略。
Eur J Pharmacol. 2004 Sep 13;498(1-3):1-8. doi: 10.1016/j.ejphar.2004.06.054.

引用本文的文献

1
Therapeutic effect of Arthrocnemum machrostachyum methanolic extract on Ehrlich solid tumor in mice.筋骨草甲醇提取物对艾氏腹水癌小鼠的治疗作用。
BMC Complement Med Ther. 2020 May 24;20(1):153. doi: 10.1186/s12906-020-02947-y.
2
A Network Pharmacology Approach to Uncover the Multiple Mechanisms of Willd. on Colorectal Cancer.一种基于网络药理学的方法揭示威灵仙治疗结直肠癌的多种机制
Evid Based Complement Alternat Med. 2018 Feb 12;2018:6517034. doi: 10.1155/2018/6517034. eCollection 2018.
3
TP53 loss creates therapeutic vulnerability in colorectal cancer.
TP53缺失导致结直肠癌出现治疗易损性。
Nature. 2015 Apr 30;520(7549):697-701. doi: 10.1038/nature14418. Epub 2015 Apr 22.
4
Small molecule compounds targeting the p53 pathway: are we finally making progress?靶向p53通路的小分子化合物:我们终于取得进展了吗?
Apoptosis. 2014 Jul;19(7):1055-68. doi: 10.1007/s10495-014-0990-3.
5
MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53.MI-63:一种靶向MDM2的新型小分子抑制剂,可诱导具有野生型p53的胚胎性和肺泡性横纹肌肉瘤细胞凋亡。
Br J Cancer. 2009 Sep 1;101(5):774-81. doi: 10.1038/sj.bjc.6605199.
6
Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and -negative leukemia cells.表没食子儿茶素-3-没食子酸酯可诱导人嗜T淋巴细胞病毒1型阳性和阴性白血病细胞发生凋亡并使细胞周期停滞。
Med Oncol. 2008;25(1):30-9. doi: 10.1007/s12032-007-0036-6. Epub 2007 Aug 14.
7
Gene therapy of liver cancer.肝癌的基因治疗。
World J Gastroenterol. 2006 Oct 14;12(38):6085-97. doi: 10.3748/wjg.v12.i38.6085.